Medifast (MED) Dividends payables (2015 - 2020)

Medifast (MED) has 6 years of Dividends payables data on file, last reported at $13.8 million in Q4 2020.

• For the quarter ending Q4 2020, Dividends payables rose 0.82% year-over-year to $13.8 million; the trailing twelve-month figure through Dec 2020 stood at $13.8 million (up 0.82% YoY), and the FY2020 full-year result was $13.8 million, up 0.82% from the prior year.
• Dividends payables for Q4 2020 stood at $13.8 million, up from $13.7 million in the prior quarter.
• Across five years, Dividends payables topped out at $13.8 million in Q4 2020 and bottomed at $4.0 million in Q4 2016.
• The 5-year median for Dividends payables is $9.1 million (2018), against an average of $9.4 million.
• The widest annual swing landed in 2017, when Dividends payables soared 51.15%; it then rose 0.82% in 2020.
• A 5-year view of Dividends payables shows it stood at $4.0 million in 2016, then surged by 51.15% to $6.1 million in 2017, then surged by 49.66% to $9.1 million in 2018, then surged by 50.15% to $13.7 million in 2019, then grew by 0.82% to $13.8 million in 2020.
• The last three Dividends payables figures came in at $13.8 million (Q4 2020), $13.7 million (Q4 2019), and $9.1 million (Q4 2018), per Business Quant data.

Peer Comparison